2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Osteochondroma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Nevus, Epithelioid and Spindle Cell
1
Myelodysplastic Syndromes
1
Malnutrition
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioblastoma
1
Giant Cell Tumors
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Merkel Cell
1
Carcinoma, Lobular
1
Carcinoma in Situ
1
Barrett Esophagus
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Surveys and Questionnaires
16
Bevacizumab
14
Cisplatin
12
Blood Specimen Collection
11
Drug Therapy
10
Standard of Care
9
Nivolumab
9
Gemcitabine
9
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
S 1 (combination)
6
Endoscopic Mucosal Resection
6
Cyclophosphamide
6
atezolizumab
5
Sunitinib
5
Radiotherapy
5
Folfox protocol
5
Educational Status
5
Docetaxel
5
fludarabine
4
aldesleukin
4
Radiosurgery
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Sampling Studies
×
Clear all
NCT02573974
2025-12-22
METERMUCADIG
University Hospital, Tours
Phase NA
Completed
51 enrolled